Medivation, Inc. Announces Participation at Upcoming Investor Conferences
Published: Nov 08, 2012
SAN FRANCISCO, CA--(Marketwire - November 07, 2012) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:
- Patrick Machado, chief business and financial officer, will present at the Jefferies 2012 Global Healthcare Conference on November 14 at 3:00p.m. in London.
- David Hung, M.D., president and chief executive officer, will present at the Credit Suisse 2012 Healthcare Conference on November 14 at 11:30a.m. in Phoenix, AZ.
- David Hung, M.D., president and chief executive officer, will present at the 24th Annual Piper Jaffray Healthcare Conference on November 27 at noon in New York, NY.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
Chief Business & Financial Officer
Sr. Director, Investor Relations